1355 related articles for article (PubMed ID: 20053690)
1. Molecular characterization of extended-spectrum beta-lactamases in clinical Escherichia coli and Klebsiella pneumoniae isolates from Surabaya, Indonesia.
Severin JA; Mertaniasih NM; Kuntaman K; Lestari ES; Purwanta M; Lemmens-Den Toom N; Duerink DO; Hadi U; van Belkum A; Verbrugh HA; Goessens WH;
J Antimicrob Chemother; 2010 Mar; 65(3):465-9. PubMed ID: 20053690
[TBL] [Abstract][Full Text] [Related]
2. Molecular epidemiology of Escherichia coli producing extended-spectrum {beta}-lactamases in Lugo (Spain): dissemination of clone O25b:H4-ST131 producing CTX-M-15.
Blanco M; Alonso MP; Nicolas-Chanoine MH; Dahbi G; Mora A; Blanco JE; López C; Cortés P; Llagostera M; Leflon-Guibout V; Puentes B; Mamani R; Herrera A; Coira MA; García-Garrote F; Pita JM; Blanco J
J Antimicrob Chemother; 2009 Jun; 63(6):1135-41. PubMed ID: 19351692
[TBL] [Abstract][Full Text] [Related]
3. Molecular characteristics of extended-spectrum beta-lactamase-producing Escherichia coli from the Chicago area: high prevalence of ST131 producing CTX-M-15 in community hospitals.
Peirano G; Costello M; Pitout JD
Int J Antimicrob Agents; 2010 Jul; 36(1):19-23. PubMed ID: 20359869
[TBL] [Abstract][Full Text] [Related]
4. Molecular epidemiology and antimicrobial susceptibility of extended- and broad-spectrum beta-lactamase-producing Klebsiella pneumoniae isolated in Portugal.
Mendonça N; Ferreira E; Louro D; ; Caniça M
Int J Antimicrob Agents; 2009 Jul; 34(1):29-37. PubMed ID: 19272757
[TBL] [Abstract][Full Text] [Related]
5. Molecular and phenotypic characterization of Escherichia coli and Klebsiella pneumoniae producing extended-spectrum β-lactamases with focus on CTX-M in a low-endemic area in Sweden.
Onnberg A; Mölling P; Zimmermann J; Söderquist B
APMIS; 2011 Apr; 119(4-5):287-95. PubMed ID: 21492229
[TBL] [Abstract][Full Text] [Related]
6. Faecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae among humans in Java, Indonesia, in 2001-2002.
Severin JA; Lestari ES; Kloezen W; Lemmens-den Toom N; Mertaniasih NM; Kuntaman K; Purwanta M; Duerink DO; Hadi U; van Belkum A; Verbrugh HA; Goessens WH;
Trop Med Int Health; 2012 Apr; 17(4):455-61. PubMed ID: 22248076
[TBL] [Abstract][Full Text] [Related]
7. Molecular epidemiology of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strains in a university hospital in Tunis, Tunisia, 1999-2005.
Elhani D; Bakir L; Aouni M; Passet V; Arlet G; Brisse S; Weill FX
Clin Microbiol Infect; 2010 Feb; 16(2):157-64. PubMed ID: 19769601
[TBL] [Abstract][Full Text] [Related]
8. Expansion and countrywide dissemination of ST11, ST15 and ST147 ciprofloxacin-resistant CTX-M-15-type beta-lactamase-producing Klebsiella pneumoniae epidemic clones in Hungary in 2005--the new 'MRSAs'?
Damjanova I; Tóth A; Pászti J; Hajbel-Vékony G; Jakab M; Berta J; Milch H; Füzi M
J Antimicrob Chemother; 2008 Nov; 62(5):978-85. PubMed ID: 18667450
[TBL] [Abstract][Full Text] [Related]
9. Dissemination of SHV-12 and CTX-M-type extended-spectrum beta-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae and emergence of GES-3 in Korea.
Ryoo NH; Kim EC; Hong SG; Park YJ; Lee K; Bae IK; Song EH; Jeong SH
J Antimicrob Chemother; 2005 Oct; 56(4):698-702. PubMed ID: 16141280
[TBL] [Abstract][Full Text] [Related]
10. Occurrence, prevalence and genetic environment of CTX-M beta-lactamases in Enterobacteriaceae from Indian hospitals.
Ensor VM; Shahid M; Evans JT; Hawkey PM
J Antimicrob Chemother; 2006 Dec; 58(6):1260-3. PubMed ID: 17071956
[TBL] [Abstract][Full Text] [Related]
11. Emergence of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae during the years 2000 and 2004 in Helsinki, Finland.
Forssten SD; Kolho E; Lauhio A; Lehtola L; Mero S; Oksaharju A; Jalava J; Tarkka E; Vaara M; Vuopio-Varkila J
Clin Microbiol Infect; 2010 Aug; 16(8):1158-61. PubMed ID: 20670290
[TBL] [Abstract][Full Text] [Related]
12. Effects of phenotype and genotype on methods for detection of extended-spectrum-beta-lactamase-producing clinical isolates of Escherichia coli and Klebsiella pneumoniae in Norway.
Tofteland S; Haldorsen B; Dahl KH; Simonsen GS; Steinbakk M; Walsh TR; Sundsfjord A;
J Clin Microbiol; 2007 Jan; 45(1):199-205. PubMed ID: 17079502
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and types of extended-spectrum beta-lactamases among urinary Escherichia coli and Klebsiella spp. in New Zealand.
Heffernan HM; Woodhouse RE; Pope CE; Blackmore TK
Int J Antimicrob Agents; 2009 Dec; 34(6):544-9. PubMed ID: 19748232
[TBL] [Abstract][Full Text] [Related]
14. CTX-M and SHV-12 beta-lactamases are the most common extended-spectrum enzymes in clinical isolates of Escherichia coli and Klebsiella pneumoniae collected from 3 university hospitals within Korea.
Kim J; Lim YM; Rheem I; Lee Y; Lee JC; Seol SY; Lee YC; Cho DT
FEMS Microbiol Lett; 2005 Apr; 245(1):93-8. PubMed ID: 15796985
[TBL] [Abstract][Full Text] [Related]
15. The DiversiLab system versus pulsed-field gel electrophoresis: characterisation of extended spectrum β-lactamase producing Escherichia coli and Klebsiella pneumoniae.
Brolund A; Hæggman S; Edquist PJ; Gezelius L; Olsson-Liljequist B; Wisell KT; Giske CG
J Microbiol Methods; 2010 Nov; 83(2):224-30. PubMed ID: 20849889
[TBL] [Abstract][Full Text] [Related]
16. [Extended-spectrum beta-lactamase in Klebsiella pneumoniae and Escherichia coli isolates].
Xiong Z; Zhu D; Zhang Y; Wang F
Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(21):1476-9. PubMed ID: 12509910
[TBL] [Abstract][Full Text] [Related]
17. Emergence of human pandemic O25:H4-ST131 CTX-M-15 extended-spectrum-beta-lactamase-producing Escherichia coli among companion animals.
Ewers C; Grobbel M; Stamm I; Kopp PA; Diehl I; Semmler T; Fruth A; Beutlich J; Guerra B; Wieler LH; Guenther S
J Antimicrob Chemother; 2010 Apr; 65(4):651-60. PubMed ID: 20118165
[TBL] [Abstract][Full Text] [Related]
18. Molecular epidemiology of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a neonatal intensive care unit.
Bagattini M; Crivaro V; Di Popolo A; Gentile F; Scarcella A; Triassi M; Villari P; Zarrilli R
J Antimicrob Chemother; 2006 May; 57(5):979-82. PubMed ID: 16531430
[TBL] [Abstract][Full Text] [Related]
19. First report of the emergence of CTX-M-type extended-spectrum beta-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system.
Lewis JS; Herrera M; Wickes B; Patterson JE; Jorgensen JH
Antimicrob Agents Chemother; 2007 Nov; 51(11):4015-21. PubMed ID: 17724160
[TBL] [Abstract][Full Text] [Related]
20. Molecular characterization of extended spectrum beta-lactamase among clinical isolates Escherichia coli and Klebsiella pneumoniae.
Udomsantisuk N; Nunthapisud P; Tirawatanapong T; Dansuputra M
J Med Assoc Thai; 2011 Dec; 94(12):1504-12. PubMed ID: 22295740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
